Investigating Real-Time Immunotherapy Symptoms Study
Recruiting
N/A
Interventional Study
Cancer
Melanoma (Skin Cancer)
Immunotherapy
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The goal of this study is to evaluate the feasibility of using information from wearable devices and self-reported symptoms to remotely monitor patients during immunotherapy. The main questions it aims to answer are:
* Is the digital remote patient monitoring tool feasible and acceptable to patients?
* Do the alerts and guidance improve symptom management, quality of life, and engagement with the…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* receiving immune checkpoint inhibitor therapy at UPMC Hillman Cancer Center for melanoma;
* age 18 years or older;
* ability to read and write in English;
* owns and uses a smartphone capable of running study applications
Exclusion Criteria:
* under 18 years old; and
* unabl…